T1FX34 Stock Overview
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Teleflex Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$133.20 |
| 52 Week High | US$135.71 |
| 52 Week Low | US$98.00 |
| Beta | 0.99 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -3.11% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -16.49% |
Recent News & Updates
Recent updates
Shareholder Returns
| T1FX34 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | 0% | -3.5% | 0.6% |
| 1Y | -3.1% | 0.2% | -8.6% |
Return vs Industry: T1FX34 underperformed the BR Medical Equipment industry which returned 0.2% over the past year.
Return vs Market: T1FX34 exceeded the BR Market which returned -8.6% over the past year.
Price Volatility
| T1FX34 volatility | |
|---|---|
| T1FX34 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in BR Market | 10.7% |
| 10% least volatile stocks in BR Market | 2.8% |
Stable Share Price: Insufficient data to determine T1FX34's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine T1FX34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1943 | 15,500 | Liam Kelly | https://www.teleflex.com |
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
Teleflex Incorporated Fundamentals Summary
| T1FX34 fundamental statistics | |
|---|---|
| Market Cap | R$54.69b |
| Earnings (TTM) | R$1.82b |
| Revenue (TTM) | R$14.33b |
30.1x
P/E Ratio3.8x
P/S RatioIs T1FX34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| T1FX34 income statement (TTM) | |
|---|---|
| Revenue | US$2.86b |
| Cost of Revenue | US$1.27b |
| Gross Profit | US$1.60b |
| Other Expenses | US$1.23b |
| Earnings | US$362.85m |
Last Reported Earnings
Apr 02, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.72 |
| Gross Margin | 55.77% |
| Net Profit Margin | 12.69% |
| Debt/Equity Ratio | 39.8% |
How did T1FX34 perform over the long term?
See historical performance and comparison